The 2004 Women and HIV Think Tank surpassed expectations by achieving all of its stated objectives as well as develping additional opportunities for collaboration and advocacy. This Think Tank meeting was the second annual gathering of the Women and HIV Think Tank Initiative, conceived by The Well Project in 2002 (later to become the Women's Research Initiative in 2005). Building on the 2003 Think Tank, the purpose of the 2004 meeting was to design and launch an action plan for coordinating a multi-disciplinarry effort to develop, track and enhance research on HIV disease in women. This year, participants evaluated three major areas of focus that were identified as critical by the 2003 Think Tank: generating and disseminating a research agenda that addresses women's issues, enhancing the participation of women in research and tracking progress of research on HIV disease in women.
The 2004 Think Tank meeting included 30 individuals representing research institutions, clinics, government agencies, advocacy organizations, and pharmaceutical companies. By engaging this diverse group of thought-leaders in a rigorous brainstorming process in full group and breakout group formats, a strong consensus emerged on the need for a coordinated action and specific plans to proceed. A list of the 2004 Women and HIV Think Tank participants can be found below.
For the full 2004 meeting report, please click the link below.
2004 Women and HIV Think Tank Participants
| Judith D. Auerbach, PhD Vice President, Public Policy amfAR |
Dawn Averitt Bridge Founder The Well Project |
| Arlene Bardeguez, MD, MPH, FACOG Associate Professor, Director HIV New Jersey Medical School, Department of OB-GYN |
Julie Barroso, PhD, ANP, CS Assistant Professor Duke University School of Nursing |
| Karen Beckerman, MD Chair, Department of OB-GYN Newark Beth Israel Medical Center |
Carol Brosgart, MD Vice President, Clinical Research Gilead Sciences |
| Gina Brown, MD Medical Director Cicatelli Associates, Inc. |
Victoria Cargill, MD, MSCE Director of Minority Research National Institutes of Health |
| Rebecca Clark, MD Associate Professor of Medicine Louisiana State University Health Sciences Center |
Susan Cohn, MD, MPH Associate Professor of Medicine University of Rochester Medical Center |
| Elaine M. Daniels, MD, PhD Senior Medical Director Therapeutic Group Leader for HIV & Women's Health Pfizer, Inc. |
Jane Hitti, MD University of Washington Medical Center |
| Tina Kanmaz, PharmD Clinical Scientist Abbott Virology |
Ben Kozub Associate Product Manager, Viramune Boehringer Ingelheim |
| Sharon Lee, MD Southwest Boulevard Family Health Care Center |
Martin Lewis, M.Ed., MSN, RNCS, ANP, ACRN Associate Director, Community Relations Gilead Sciences |
| Veronica Miller, PhD Director Forum for Collaborative HIV Research |
Donne Newbury, PhD Bristol-Myers Squibb |
| Karin Nielsen, MD, MPH Associate Clinical Professor, Pediatric Infectious Diseases UCLA Department of Pediatrics |
Nancy Norman, MD, MPH Director of Women's Health Fenway Community Health |
| Keri Oberg National Manager, HIV Community Relations Boehringer Ingelheim |
Andrew Pavia, MD Professor of Pediatrics and Medicine University of Utah |
| Tonia Poteat, PA-C Grady Infectious Disease Program |
Patricia Reichelderfer, PhD Microbiologist NIH/NICHD |
| Stephen Storfer, MD Associate Director, Virology Clinical and Scientific Affairs Boehringer Ingelheim Pharmaceuticals, Inc. |
Melanie Thompson, MD Principal Investigator AIDS Research Consortium of Atlanta |
| Jennifer VanHorn, MD Department of OB-GYN University of Utah |
Fulvia Veronese, PhD Chair, Etiology and Pathogenesis and Microbicides Research National Institutes of Health |
Meeting Staff
Richard Averitt
Chief Operating Officer
The Well Project
Megan Raspa
Project Manager
The Well Project
Facilitators
Rachel Conerly
Ron Wilder
Aligned Action, Inc.
Meeting Planners
Debbie Cooke
VP, Chief Operations Officer
Meeting Masters, Inc.
Tina DeRenzis
President
Meeting Masters, Inc.
